Bruce C. Cozadd
2013
In 2013, Bruce C. Cozadd earned a total compensation of $8.3M as Chairman and Chief Executive Officer at Jazz Pharmaceuticals, a 26% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $1,056,500 |
|---|---|
| Option Awards | $3,478,750 |
| Salary | $771,154 |
| Stock Awards | $2,956,500 |
| Other | $3,622 |
| Total | $8,266,526 |
Cozadd received $3.5M in option awards, accounting for 42% of the total pay in 2013.
Cozadd also received $1.1M in non-equity incentive plan, $771.2K in salary, $3M in stock awards and $3.6K in other compensation.
Rankings
In 2013, Bruce C. Cozadd's compensation ranked 586th out of 12,286 executives tracked by ExecPay. In other words, Cozadd earned more than 95.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 586 out of 12,286 | 95th |
Division Manufacturing | 181 out of 4,614 | 96th |
Major group Chemicals And Allied Products | 44 out of 1,466 | 97th |
Industry group Drugs | 26 out of 1,160 | 98th |
Industry Pharmaceutical Preparations | 24 out of 890 | 97th |
Source: SEC filing on June 20, 2016.
Cozadd's colleagues
We found four more compensation records of executives who worked with Bruce C. Cozadd at Jazz Pharmaceuticals in 2013.
News
Jazz Pharmaceuticals CEO Bruce Cozadd's 2021 pay jumps 25% to $16M
June 10, 2022
Jazz Pharmaceuticals CEO Bruce Cozadd's 2020 pay slips 15% to $13M
June 11, 2021
Jazz Pharmaceuticals CEO Bruce Cozadd's 2019 pay jumps 29% to $15M
June 12, 2020
Jazz Pharmaceuticals CEO Bruce Cozadd's 2018 pay rises 11% to $11M
June 14, 2019